Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
This story comes from CNBC's feed; the full article and all rights belong to the source.
Comments (0)
No comments yet. Be the first to comment.
Sign in to write a comment.